Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bendamustine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01141725
What this trial is testing

Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+6 more
Fred Hutchinson Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT04569838
What this trial is testing

Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection

Who this might be right for
Indolent B-Cell Non-Hodgkin's Lymphomas
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 91
Early research (Phase 1)Ended earlyNCT02168907
What this trial is testing

CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic LeukemiaCutaneous B-cell Non-Hodgkin Lymphoma+24 more
Wake Forest University Health Sciences 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04115631
What this trial is testing

A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Liver LymphomaMantle Cell Lymphoma
ECOG-ACRIN Cancer Research Group 360
Large-scale testing (Phase 3)Active Not RecruitingNCT04002297
What this trial is testing

Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation

Who this might be right for
Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
BeOne Medicines 510
Early research (Phase 1)Ended earlyNCT00947388
What this trial is testing

Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Recurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+3 more
Case Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)WithdrawnNCT01332617
What this trial is testing

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Who this might be right for
Myeloma
University of Louisville
Testing effectiveness (Phase 2)Study completedNCT01486797
What this trial is testing

NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
TME Pharma AG 28
Testing effectiveness (Phase 2)Ended earlyNCT01179490
What this trial is testing

Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
SymBio Pharmaceuticals 5
Not applicableStudy completedNCT02381899
What this trial is testing

Observational Study in CLL Patients Receiving BR

Who this might be right for
Chronic Lymphocytic Leukemia
Czech CLL Study Group 83
Testing effectiveness (Phase 2)Study completedNCT02414568
What this trial is testing

Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin

Who this might be right for
Classical Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05918276
What this trial is testing

Clinical Study of Orelabrutinib Combined With BG Regimen First-line Treatment of CLL/SLL

Who this might be right for
CLL/SLL
Nanfang Hospital, Southern Medical University 24
Large-scale testing (Phase 3)Study completedNCT07450508
What this trial is testing

Study of Bendamustine, Gemcitabine and Vinorelbine Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma Relapsed
Cairo University 88
Early research (Phase 1)Study completedNCT01042704
What this trial is testing

Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

Who this might be right for
Myeloma
Robert Redner, MD 29
Testing effectiveness (Phase 2)WithdrawnNCT01238146
What this trial is testing

Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01612988
What this trial is testing

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL

Who this might be right for
B-cell Chronic Lymphocytic Leukemia (B-CLL)
French Innovative Leukemia Organisation 74
Testing effectiveness (Phase 2)Study completedNCT00984542
What this trial is testing

Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00274989
What this trial is testing

Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 195
Early research (Phase 1)Ended earlyNCT04083898
What this trial is testing

Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 15
Testing effectiveness (Phase 2)Study completedNCT01049945
What this trial is testing

Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
Mayo Clinic 70
Next Page